How Does Hyperkalemia Affect Action Potential?

Hyperkalemia disrupts action potentials by shifting the electrical baseline of excitable cells. When potassium accumulates outside cells, the voltage difference across the cell membrane shrinks, and that smaller voltage gap interferes with the channels responsible for firing and conducting electrical signals. The consequences show up most dangerously in the heart, but the same basic disruption affects skeletal muscle and peripheral nerves in ways that explain a range of symptoms from muscle weakness to abnormal reflexes.

What Happens to the Resting Membrane Potential

Every excitable cell in your body maintains a resting voltage across its membrane, with the inside sitting more negative than the outside. Potassium is the main ion responsible for setting this voltage, because potassium channels that are open at rest let the ion flow freely in and out. Under normal conditions, the concentration of potassium inside cells is much higher than outside, and this imbalance creates the electrical gradient that keeps the resting voltage around –90 millivolts in heart muscle cells.

When extracellular potassium rises, the concentration difference between inside and outside shrinks. The resting voltage moves closer to zero, a shift called depolarization. At a potassium level of around 6 to 7 millimoles per liter (normal is roughly 3.5 to 5), the resting potential might sit at –80 millivolts instead of –90. Push that potassium to 8 or 9 millimoles per liter and the resting potential can climb to –70 or –65 millivolts. This shift sounds modest in absolute terms, but it has outsized effects on the channels that generate action potentials, because those channels are exquisitely sensitive to the starting voltage of the cell.¹

The Biphasic Effect on Excitability

One of the more counterintuitive aspects of hyperkalemia is that mild and severe elevations do opposite things to how easily a cell can be triggered. When potassium is only modestly elevated, the resting potential sits closer to the threshold needed to fire an action potential. Think of it as starting partway up a staircase: less additional push is needed to reach the top. At this stage, cells are actually more excitable than normal, and in the heart, conduction speed can temporarily increase.

Once potassium climbs further, however, the picture reverses. The depolarized resting potential begins to inactivate sodium channels, the very channels that need to snap open to generate the rapid upstroke of the action potential. Sodium channels have a built-in safety feature: if the membrane voltage sits too high for too long, they lock into an inactivated state and refuse to open even when the cell is stimulated. The result is that above roughly 7 to 9 millimoles per liter, excitability drops sharply, and conduction velocity slows.² Research in rabbit hearts confirmed this biphasic pattern: at moderate elevations cells could still be triggered normally, but once extracellular potassium reached 8 to 9 millimoles per liter, the mechanism of stimulation changed and excitability thresholds rose sharply.³

This biphasic behavior explains why patients with mildly elevated potassium sometimes look fine on a monitor while patients with severely elevated levels can deteriorate rapidly. The transition from “slightly more excitable” to “dangerously under-excitable” can happen over a narrow range of potassium values.

How the Action Potential Upstroke Weakens

The fast upstroke of a cardiac or nerve action potential depends on sodium channels opening in a coordinated rush. When the resting membrane potential is normal, a large pool of sodium channels sits in the “ready” state, waiting for the voltage to hit threshold. Once it does, they open almost simultaneously, and sodium floods into the cell, driving the voltage sharply positive. That steep upstroke is what allows the electrical signal to propagate quickly from cell to cell.

Hyperkalemia erodes this system from the ground up. Because the resting potential is already partially depolarized, a fraction of sodium channels have drifted into their inactivated state before the cell even tries to fire. Fewer available channels mean the upstroke is slower and smaller. A weaker upstroke produces a weaker electrical current to depolarize neighboring cells, so the wave of excitation travels more slowly through tissue. In the heart, this slowing of conduction is one of the primary ways hyperkalemia sets the stage for rhythm disturbances.⁴

At very high potassium levels, so many sodium channels are inactivated that cells may become completely inexcitable. At that point, no action potential can be generated at all, and conduction stops. In the heart, this can manifest as a wide, bizarre-looking electrical signal that eventually degenerates into a lethal rhythm or asystole.

What Shows Up on the ECG

Because different regions of the heart are affected at slightly different potassium thresholds, the electrocardiogram evolves in a somewhat predictable sequence as potassium rises. The earliest and most recognizable change is tall, peaked T waves, which reflect altered repolarization of the ventricles. As potassium climbs further, the PR interval lengthens because conduction through the atria and the atrioventricular node slows. The P wave may flatten and eventually disappear entirely, meaning the atria have essentially stopped conducting. The QRS complex widens as ventricular conduction slows, and at critically high levels the QRS merges with the T wave to produce a smooth, undulating “sine wave” pattern.⁵

These ECG changes are directly traceable to the action potential changes described above. Peaked T waves appear because higher extracellular potassium increases the driving force for potassium leaving the cell during repolarization, making the repolarization phase faster and more abrupt. The widened QRS reflects the weakened and slower upstroke in ventricular muscle. The loss of P waves tells you the atrial cells have been depolarized to the point where their sodium channels can no longer fire effectively. Each stage on the ECG is a readable footprint of what is happening to the action potential at the cellular level.

One important caveat: these “classic” ECG changes are a teaching framework, not a reliable diagnostic sequence in every patient. Some people with dangerously high potassium show minimal ECG changes, while others develop wide QRS complexes at levels that would produce only peaked T waves in a textbook. Clinical decisions should never rely solely on the ECG pattern.

How Hyperkalemia Creates Dangerous Heart Rhythms

The combination of slowed conduction and prolonged refractoriness creates the perfect conditions for a type of arrhythmia called reentry. In a healthy heart, an electrical signal travels smoothly in one direction and then dies out because every cell it encounters has already fired and is temporarily unresponsive. Reentry occurs when the signal finds a pathway where some cells have recovered while others haven’t, allowing the wave to circle back and restimulate tissue that has just become re-excitable.

Hyperkalemia promotes reentry in two ways. First, by slowing conduction, it gives already-activated tissue more time to recover before the wavefront arrives back around. Second, by extending the refractory period unevenly across different layers of heart tissue, it creates pockets where the timing of recovery differs sharply from the surrounding muscle. Computational modeling of ischemic heart tissue showed that as extracellular potassium rose from 10 to 12 millimoles per liter, the refractory period in surviving muscle layers extended significantly while conduction velocity dropped, widening the gap in electrical properties between ischemic and healthy zones. That gap was enough to let a premature stimulus loop back through the tissue and sustain a reentrant circuit.⁶

This is why hyperkalemia during a heart attack is especially dangerous. The ischemic zone already has reduced blood flow and locally elevated potassium from dying cells, and if systemic potassium is also high, the electrophysiological mismatch between healthy and ischemic tissue becomes extreme. Ventricular tachycardia and ventricular fibrillation are the predictable results.

Effects on Skeletal Muscle

The heart gets the most clinical attention, but the same action potential disruption occurs in skeletal muscle. Under normal conditions, a rise in extracellular potassium after vigorous exercise is quickly buffered. In hyperkalemia, the persistently elevated potassium depolarizes skeletal muscle fibers, inactivating their sodium channels and reducing their ability to fire action potentials. The clinical result is muscle weakness, which can progress to frank paralysis if levels are high enough.

A dramatic illustration of this mechanism is hyperkalemic periodic paralysis, a genetic condition in which a mutation in the sodium channel gene makes those channels abnormally sensitive to potassium. In people with this condition, a moderate rise in extracellular potassium pushes a fraction of mutant sodium channels into a persistent open state. The steady sodium current further depolarizes the membrane, which then inactivates the remaining normal sodium channels. The cell becomes unable to generate action potentials, and the muscle goes limp.⁷ This condition underscores a broader point: the mechanism of depolarization-induced inexcitability is the shared pathway for paralytic attacks across several forms of periodic paralysis, regardless of the specific underlying mutation.⁸

Even without a genetic predisposition, patients with severe hyperkalemia from kidney failure or medication effects can experience generalized weakness that mimics aspects of these inherited conditions. The weakness tends to affect the limbs more than the respiratory muscles, but in extreme cases breathing can be compromised.

Effects on Peripheral Nerves

Peripheral nerves are also excitable tissue, and their action potentials rely on the same sodium channel machinery. Studies of patients with chronic kidney failure have shown that nerves become measurably depolarized when serum potassium is elevated, even at levels that aren’t dramatically above normal. Before dialysis, patients showed reduced superexcitability and altered threshold behavior in nerve conduction studies, patterns that closely matched what you see when you experimentally depolarize a normal nerve. These abnormalities correlated with serum potassium levels but not with other markers of kidney dysfunction like urea or creatinine, strongly suggesting that potassium itself was the culprit.⁹

After dialysis lowered potassium levels, the nerve conduction abnormalities improved. Researchers confirmed this was specifically a potassium effect by performing dialysis sessions against a high-potassium dialysate, which kept potassium elevated even as other waste products were cleared. Under those conditions, the nerve abnormalities persisted. Only when dialysis actually lowered potassium did excitability return to normal.¹⁰ This raises an interesting possibility: chronic hyperkalemia, even at moderate levels, may contribute to the nerve damage commonly seen in kidney disease patients, a condition traditionally blamed on the accumulation of other uremic toxins.

Why Emergency Calcium Treatment Works Differently Than You’d Think

When a patient presents with dangerous hyperkalemia and ECG changes, the first-line treatment is intravenous calcium. The traditional explanation taught in medical training is that calcium “stabilizes the membrane,” essentially resetting the resting potential toward normal and restoring sodium channel availability. This explanation is intuitive, but recent research suggests it is probably wrong.

A 2024 study found that calcium treatment did not actually restore the resting membrane potential in hyperkalemic cardiac tissue. The cells remained depolarized after calcium was given. Instead, calcium appeared to rescue conduction through a completely different route: by enabling calcium-dependent propagation. When sodium channels are largely inactivated by hyperkalemia, L-type calcium channels can partially take over the job of carrying the depolarizing current from cell to cell. Calcium infusion enhances this backup conduction pathway. Supporting this interpretation, when researchers blocked L-type calcium channels, the protective effect of calcium treatment was significantly reduced.¹¹

This distinction matters more than it might seem. If calcium worked by fixing the resting potential, you’d expect the action potential to return to something resembling normal. If it works by engaging a calcium-dependent conduction pathway instead, the action potential in treated tissue is fundamentally different from the healthy version, slower and more dependent on calcium channel kinetics. Understanding this mechanism could eventually change how clinicians combine calcium with other treatments and how they interpret the ECG changes that follow calcium administration.

Shifting Potassium Back Into Cells

While calcium buys time by keeping the heart conducting, the definitive approach is to move potassium out of the extracellular space. Two commonly used treatments exploit the body’s own mechanisms for shuttling potassium into cells. Insulin activates the sodium-potassium pump on cell membranes, driving potassium inward regardless of whether glucose is present. Beta-2 adrenergic agonists, the same class of drugs used in asthma inhalers, do the same thing through a different signaling pathway that also activates the sodium-potassium pump.¹² Neither treatment removes potassium from the body; they redistribute it from extracellular fluid into cells, buying time for the kidneys or dialysis to eliminate the excess. The action potential benefits because what matters is the concentration gradient across the membrane, not the total body potassium. Lowering the extracellular concentration restores the gradient toward normal, pulls the resting potential back down, and releases sodium channels from their inactivated state.

Why Not All Patients Follow the Textbook

One of the most frustrating aspects of hyperkalemia in clinical practice is how poorly the serum potassium number predicts the severity of the electrophysiological effects. Some patients tolerate potassium levels above 7 with minimal ECG changes, while others develop dangerous rhythms at 6. Several factors explain this variability.

The speed of the rise matters enormously. A potassium level that climbs over hours during acute kidney injury is generally more dangerous than the same number reached gradually over weeks in a patient with chronic kidney disease. Cells have some ability to adapt to a slowly changing environment, adjusting intracellular ion concentrations and channel expression. That said, the evidence on whether chronic hyperkalemia truly produces fewer arrhythmias than acute hyperkalemia is less clear-cut than the traditional teaching suggests.

Coexisting electrolyte abnormalities also modulate the effect. Calcium, sodium, and magnesium levels all influence how sodium and potassium channels behave. Low calcium amplifies the effect of hyperkalemia on excitability, while normal or high calcium provides some buffering. Acidosis, which often accompanies hyperkalemia, independently shifts potassium out of cells and may worsen the electrophysiological effects. The relationship between conduction velocity and potassium in the heart is itself modulated by both sodium and calcium concentrations, meaning the same potassium level produces different conduction changes depending on the rest of the electrolyte panel.²

Underlying heart disease further complicates the picture. A heart with scarring from a prior heart attack already has regions of slow conduction and patchy refractoriness. Adding hyperkalemia to that substrate widens the electrical mismatch and makes reentrant arrhythmias far more likely at lower potassium levels than would be dangerous in a structurally normal heart. This is why the clinical threshold for treating hyperkalemia is generally lower in patients with known cardiac disease.

Glial Cells and the Brain

While the heart and skeletal muscle receive the most attention, extracellular potassium also plays a major role in the brain, where glial cells act as potassium buffers. During intense neuronal activity, neurons release potassium into the extracellular space. Glial cells absorb this excess, preventing the kind of runaway depolarization that would silence surrounding neurons. Measurements in mammalian cortex have shown that during sustained elevations in extracellular potassium, such as those occurring during seizure-like episodes, glial cell depolarization tracks closely with the potassium concentration as predicted by classical electrochemical relationships.¹³

This buffering system works well under normal circumstances, but it can be overwhelmed. During seizures, spreading cortical depression, or traumatic brain injury, local potassium concentrations can spike dramatically. The resulting depolarization of surrounding neurons alters their action potentials in ways closely analogous to what happens in the heart during systemic hyperkalemia. Whether systemic hyperkalemia from kidney disease or other causes raises brain extracellular potassium enough to meaningfully affect neuronal firing is less well established, partly because measuring brain extracellular potassium in living patients is far more difficult than measuring it in blood. But the basic vulnerability is there: neurons, like cardiomyocytes and skeletal muscle fibers, depend on a potassium gradient they did not evolve to maintain against large external shifts.